APA (7th ed.) Citation

Reccardini, N., Chernovsky, M., Salton, F., Confalonieri, P., Mondini, L., Barbieri, M., . . . Ruaro, B. (2024). Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant. Pharmaceuticals (14248247), 17(7), 930. https://doi.org/10.3390/ph17070930

Chicago Style (17th ed.) Citation

Reccardini, Nicolò, et al. "Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant." Pharmaceuticals (14248247) 17, no. 7 (2024): 930. https://doi.org/10.3390/ph17070930.

MLA (9th ed.) Citation

Reccardini, Nicolò, et al. "Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant." Pharmaceuticals (14248247), vol. 17, no. 7, 2024, p. 930, https://doi.org/10.3390/ph17070930.